Alnexia
Connecting global compliance to patient empowerment

Providing Structured Format Labeling Solutions

Alnexia delivers four parallel service lines for Marketing Authorisation Holders — ePI (EMA FHIR), Regulatory Labeling, FDA SPL and Artwork Management. Engage any one on its own, or run the full label lifecycle with a single partner.

Explore our services See the workflow
Our Objective

The definitive partner for integrated labeling excellence.

We pioneer and promote a seamless global digital transformation ecosystem that standardizes and strengthens labeling requirements across the healthcare industry — establishing Alnexia as the go-to ePI partner for regulatory leaders, biotech innovators and global Marketing Authorisation Holders.

EMA PLM Portal aligned
HL7 FHIR EU ePI IG v1.0.0
SPOR / IDMP referentials
Key Benefits

Value on both sides of the pack.

For our customers

  • Lower burden on graphic design, QC and printing
  • Avoid destruction of stock during labeling updates
  • Reduced packaging size and material waste
  • Faster implementation of safety updates
  • No more millions of paper inserts discarded annually

For patients

  • Better readability and searchability
  • Faster access to updated information
  • Customisable formats — large text, audio, preferred language
  • Integrated information across multiple therapies

Ready for the 2028 mandatory transition?

Whether you’re piloting vaccines in Q3 2026 or planning your full portfolio migration, we’ll help you ship compliant FHIR ePI bundles — measured, audited and validated.

Book a consultation View EMA timeline